Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joel D Ernst

Showing results (1-10 of 123) with videos related to

Pageof 13
Sort By:
American Journal of Respiratory and Critical Care Medicine|December 21, 2017
Float Like Bacilli, STING Like a B: Type I Interferons in TuberculosisJoel D Ernst
Cell Host & Microbe|July 13, 2018
Mechanisms of M. tuberculosis Immune Evasion as Challenges to TB Vaccine DesignJoel D Ernst
The Journal of Infectious Diseases|December 11, 2025
Clinical Commentary on: Targeting Tryptophan Metabolism for Tuberculosis Biomarkers and Host Directed TherapyJoel D Ernst
Nature Reviews. Immunology|July 14, 2012
The immunological life cycle of tuberculosisJoel D Ernst
Advances in Experimental Medicine and Biology|November 9, 2017
Antigenic Variation and Immune Escape in the MTBCJoel D Ernst
Journal of Immunology (Baltimore, Md. : 1950)|May 11, 2011
Lung neutrophils facilitate activation of naive antigen-specific CD4+ T cells during Mycobacterium tuberculosis infectionRobert Blomgran, Joel D Ernst
Journal of Immunology (Baltimore, Md. : 1950)|July 3, 2013
Cutting edge: Direct recognition of infected cells by CD4 T cells is required for control of intracellular Mycobacterium tuberculosis in vivoSmita Srivastava, Joel D Ernst
Immunity|January 13, 2010
Interferon-gamma-responsive nonhematopoietic cells regulate the immune response to Mycobacterium tuberculosisLudovic Desvignes, Joel D Ernst
Nature Medicine|January 5, 2023
Finding antigens for TB vaccines: the good, the bad and the uselessPaul Ogongo, Joel D Ernst
Cell Host & Microbe|May 14, 2008
CO-opting the host HO-1 pathway in tuberculosis and malariaPhotini Sinnis, Joel D Ernst
Pageof 13

Showing results (1-10 of 123) with videos related to

Sort By:
Pageof 13
American Journal of Respiratory and Critical Care Medicine|December 21, 2017
Float Like Bacilli, STING Like a B: Type I Interferons in TuberculosisJoel D Ernst
Cell Host & Microbe|July 13, 2018
Mechanisms of M. tuberculosis Immune Evasion as Challenges to TB Vaccine DesignJoel D Ernst
The Journal of Infectious Diseases|December 11, 2025
Clinical Commentary on: Targeting Tryptophan Metabolism for Tuberculosis Biomarkers and Host Directed TherapyJoel D Ernst
Nature Reviews. Immunology|July 14, 2012
The immunological life cycle of tuberculosisJoel D Ernst
Advances in Experimental Medicine and Biology|November 9, 2017
Antigenic Variation and Immune Escape in the MTBCJoel D Ernst
Journal of Immunology (Baltimore, Md. : 1950)|May 11, 2011
Lung neutrophils facilitate activation of naive antigen-specific CD4+ T cells during Mycobacterium tuberculosis infectionRobert Blomgran, Joel D Ernst
Journal of Immunology (Baltimore, Md. : 1950)|July 3, 2013
Cutting edge: Direct recognition of infected cells by CD4 T cells is required for control of intracellular Mycobacterium tuberculosis in vivoSmita Srivastava, Joel D Ernst
Immunity|January 13, 2010
Interferon-gamma-responsive nonhematopoietic cells regulate the immune response to Mycobacterium tuberculosisLudovic Desvignes, Joel D Ernst
Nature Medicine|January 5, 2023
Finding antigens for TB vaccines: the good, the bad and the uselessPaul Ogongo, Joel D Ernst
Cell Host & Microbe|May 14, 2008
CO-opting the host HO-1 pathway in tuberculosis and malariaPhotini Sinnis, Joel D Ernst
Pageof 13